Researchers are shifting focus from large arteries to microvessels, where nitric oxide activity may signal early circulatory ...

Clarametyx today announced positive topline data from a Phase 1b/2a trial evaluating its novel antibody therapy, CMTX-101, in cystic fibrosis (CF).

Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2 ...

This means that early diagnostic tests, particularly in the first 42 hours after a baby is born, can detect many health conditions before the damage begins. It also supports the baby's long-term ...